Palisade Bio (PALI) Cash from Investing Activities Growth (1y) (2011 - 2021)
Powered by 
Analysis
Palisade Bio (PALI) Cash from Investing Activities Growth (1y) (2011 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 90.55% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 91.53% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -41.67% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -157.08% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 26.37% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -89.24% |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | -34,900.00% |
| Dec 31, 2018 | -320.10% |
| Dec 31, 2017 | 99.99% |
| Dec 31, 2016 | -97.06% |
| Jun 30, 2016 | -8.61% |
| Mar 31, 2016 | 7,721.50% |
| Dec 31, 2015 | -3,258.65% |
| Sep 30, 2015 | 10,607.29% |
| Jun 30, 2015 | 45.19% |
| Mar 31, 2015 | 99.35% |
| Dec 31, 2014 | 17.64% |
| Sep 30, 2014 | 54.09% |
| Jun 30, 2014 | -20.42% |
| Mar 31, 2014 | -15,623.64% |
| Dec 31, 2013 | -38.76% |
| Sep 30, 2013 | -436.20% |
| Jun 30, 2013 | -16.43% |
| Mar 31, 2013 | -236.54% |
| Dec 31, 2012 | -9.46% |
| Sep 30, 2012 | 70.83% |